Dahan Michel 4
4 · Akebia Therapeutics, Inc. · Filed May 16, 2023
Insider Transaction Report
Form 4
Dahan Michel
SVP, Chief Business Officer
Transactions
- Award
Common Stock
2023-05-12+200,000→ 469,515 total
Footnotes (1)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.